🇺🇸 FDA
Patent

US 11708364

Azaindole derivatives and their use as ERK kinase inhibitors

granted A61KA61K31/4353A61P

Quick answer

US patent 11708364 (Azaindole derivatives and their use as ERK kinase inhibitors) held by AGV Discovery expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AGV Discovery
Grant date
Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/4353, A61P, A61P35/00